REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.
It is not known if REBLOZYL is safe or effective in children under 18 years of age.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Your treatment plan and your goals will go hand-in-hand, helping guide your healthcare team’s decisions. It’s important to talk openly with your healthcare team about what you’re looking for from a treatment plan. These conversations can help you and your healthcare team understand what your goals might be.
To make the most out of any treatment, it’s important to keep track of how you respond to that treatment. Tracking how you feel right from the start of treatment and sharing your notes with your healthcare team provides them with important information that allows them to make adjustments to your treatment.
Depending on the type of appointment, make sure to write down the following:
Your appointment is your time. Take notes and don’t hold back any questions. Bringing someone with you can be helpful.